{"transactions":[{"id":711870,"issuer":{"id":4763,"kind":"organization","name":"Vor Biopharma Inc.","symbol":"VOR"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-09T20:01:02.000Z","date":"2026-07-07","kind":"grant","planned":false,"acquired":true,"shares":42658,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares shall vest and become exercisable in a series of 36 successive equal monthly installments beginning on August 7, 2026, in each case subject to the Reporting Person's continued service as of each such date."}],"balance_after":42658,"derivative":{"exercise_price":20.1,"expiration_date":"2036-07-06","underlying":"Common Stock","underlying_shares":42658},"source":{"system":"sec-edgar","filing":"0001193125-26-299665","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817229/000119312526299665/ownership.xml","form_type":"4"}},{"id":945262,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-07T21:40:03.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the inaugural grant to the Reporting Person as a member of the Board of Directors of the Issuer. Shares underlying the option vest in three equal annual installments on January 5, 2027, January 5, 2028 and January 5, 2029."},{"field":"security","element":"securityTitle","label":"F2","text":"This award was made pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the inaugural grant to the Reporting Person as a member of the Board of Directors of the Issuer. Shares underlying the option vest in three equal annual installments on January 5, 2027, January 5, 2028 and January 5, 2029."}],"balance_after":240000,"derivative":{"exercise_price":3.74,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001193125-26-006427","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000119312526006427/ownership.xml","form_type":"4"}},{"id":1021440,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Unit","published_at":"2025-10-08T20:44:12.000Z","date":"2025-10-07","kind":"exercise","planned":false,"acquired":false,"shares":1649952,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Represents an award of RSUs covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"These performance-based restricted share unit awards (the \"PRSUs\") were earned upon the determination by the Board of Directors of the Issuer that certain performance metrics had been achieved. Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the PRSUs, unless agreed otherwise, became fully vested, and at the Effective Time, were automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such PRSU Award and (ii) the ADS Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"These performance-based restricted share unit awards (the \"PRSUs\") were earned upon the determination by the Board of Directors of the Issuer that certain performance metrics had been achieved. Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the PRSUs, unless agreed otherwise, became fully vested, and at the Effective Time, were automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such PRSU Award and (ii) the ADS Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These performance-based restricted share unit awards (the \"PRSUs\") were earned upon the determination by the Board of Directors of the Issuer that certain performance metrics had been achieved. Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the PRSUs, unless agreed otherwise, became fully vested, and at the Effective Time, were automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such PRSU Award and (ii) the ADS Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"These performance-based restricted share unit awards (the \"PRSUs\") were earned upon the determination by the Board of Directors of the Issuer that certain performance metrics had been achieved. Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the PRSUs, unless agreed otherwise, became fully vested, and at the Effective Time, were automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such PRSU Award and (ii) the ADS Consideration."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1649952},"source":{"system":"sec-edgar","filing":"0001104659-25-097966","document":"tm2528014-13_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925097966/tm2528014-13_4seq1.xml","form_type":"4"}},{"id":1021439,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Unit","published_at":"2025-10-08T20:44:12.000Z","date":"2025-10-07","kind":"grant","planned":false,"acquired":true,"shares":1649952,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Represents an award of RSUs covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"These performance-based restricted share unit awards (the \"PRSUs\") were earned upon the determination by the Board of Directors of the Issuer that certain performance metrics had been achieved. Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the PRSUs, unless agreed otherwise, became fully vested, and at the Effective Time, were automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such PRSU Award and (ii) the ADS Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"These performance-based restricted share unit awards (the \"PRSUs\") were earned upon the determination by the Board of Directors of the Issuer that certain performance metrics had been achieved. Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the PRSUs, unless agreed otherwise, became fully vested, and at the Effective Time, were automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such PRSU Award and (ii) the ADS Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These performance-based restricted share unit awards (the \"PRSUs\") were earned upon the determination by the Board of Directors of the Issuer that certain performance metrics had been achieved. Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the PRSUs, unless agreed otherwise, became fully vested, and at the Effective Time, were automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such PRSU Award and (ii) the ADS Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"These performance-based restricted share unit awards (the \"PRSUs\") were earned upon the determination by the Board of Directors of the Issuer that certain performance metrics had been achieved. Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the PRSUs, unless agreed otherwise, became fully vested, and at the Effective Time, were automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such PRSU Award and (ii) the ADS Consideration."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":1649952,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1649952},"source":{"system":"sec-edgar","filing":"0001104659-25-097966","document":"tm2528014-13_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925097966/tm2528014-13_4seq1.xml","form_type":"4"}},{"id":1021438,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Unit","published_at":"2025-10-08T20:44:12.000Z","date":"2025-10-07","kind":"exercise","planned":false,"acquired":false,"shares":445536,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Represents an award of RSUs covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding time-based restricted share unit award (\"RSU Award\"), unless agreed otherwise, became fully vested, and at the Effective Time, was automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such RSU Award and (ii) the ADS Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding time-based restricted share unit award (\"RSU Award\"), unless agreed otherwise, became fully vested, and at the Effective Time, was automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such RSU Award and (ii) the ADS Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding time-based restricted share unit award (\"RSU Award\"), unless agreed otherwise, became fully vested, and at the Effective Time, was automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such RSU Award and (ii) the ADS Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding time-based restricted share unit award (\"RSU Award\"), unless agreed otherwise, became fully vested, and at the Effective Time, was automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such RSU Award and (ii) the ADS Consideration."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":445536},"source":{"system":"sec-edgar","filing":"0001104659-25-097966","document":"tm2528014-13_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925097966/tm2528014-13_4seq1.xml","form_type":"4"}},{"id":1021437,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Unit","published_at":"2025-10-08T20:44:12.000Z","date":"2025-10-07","kind":"exercise","planned":false,"acquired":false,"shares":389792,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Represents an award of RSUs covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding time-based restricted share unit award (\"RSU Award\"), unless agreed otherwise, became fully vested, and at the Effective Time, was automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such RSU Award and (ii) the ADS Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding time-based restricted share unit award (\"RSU Award\"), unless agreed otherwise, became fully vested, and at the Effective Time, was automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such RSU Award and (ii) the ADS Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding time-based restricted share unit award (\"RSU Award\"), unless agreed otherwise, became fully vested, and at the Effective Time, was automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such RSU Award and (ii) the ADS Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding time-based restricted share unit award (\"RSU Award\"), unless agreed otherwise, became fully vested, and at the Effective Time, was automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such RSU Award and (ii) the ADS Consideration."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":389792},"source":{"system":"sec-edgar","filing":"0001104659-25-097966","document":"tm2528014-13_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925097966/tm2528014-13_4seq1.xml","form_type":"4"}},{"id":1021436,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Unit","published_at":"2025-10-08T20:44:12.000Z","date":"2025-10-07","kind":"exercise","planned":false,"acquired":false,"shares":800000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Represents an award of RSUs covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"These performance-based restricted share unit awards (the \"PRSUs\") were earned upon the determination by the Board of Directors of the Issuer that certain performance metrics had been achieved. Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the PRSUs, unless agreed otherwise, became fully vested, and at the Effective Time, were automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such PRSU Award and (ii) the ADS Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"These performance-based restricted share unit awards (the \"PRSUs\") were earned upon the determination by the Board of Directors of the Issuer that certain performance metrics had been achieved. Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the PRSUs, unless agreed otherwise, became fully vested, and at the Effective Time, were automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such PRSU Award and (ii) the ADS Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding time-based restricted share unit award (\"RSU Award\"), unless agreed otherwise, became fully vested, and at the Effective Time, was automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such RSU Award and (ii) the ADS Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding time-based restricted share unit award (\"RSU Award\"), unless agreed otherwise, became fully vested, and at the Effective Time, was automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such RSU Award and (ii) the ADS Consideration."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001104659-25-097966","document":"tm2528014-13_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925097966/tm2528014-13_4seq1.xml","form_type":"4"}},{"id":1021435,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-10-08T20:44:12.000Z","date":"2025-10-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3285280,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding time-based restricted share unit award (\"RSU Award\"), unless agreed otherwise, became fully vested, and at the Effective Time, was automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such RSU Award and (ii) the ADS Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"These performance-based restricted share unit awards (the \"PRSUs\") were earned upon the determination by the Board of Directors of the Issuer that certain performance metrics had been achieved. Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the PRSUs, unless agreed otherwise, became fully vested, and at the Effective Time, were automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such PRSU Award and (ii) the ADS Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-25-097966","document":"tm2528014-13_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925097966/tm2528014-13_4seq1.xml","form_type":"4"}},{"id":1021434,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-10-08T20:44:12.000Z","date":"2025-10-07","kind":"exercise","planned":false,"acquired":true,"shares":3285280,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding time-based restricted share unit award (\"RSU Award\"), unless agreed otherwise, became fully vested, and at the Effective Time, was automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such RSU Award and (ii) the ADS Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"These performance-based restricted share unit awards (the \"PRSUs\") were earned upon the determination by the Board of Directors of the Issuer that certain performance metrics had been achieved. Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the PRSUs, unless agreed otherwise, became fully vested, and at the Effective Time, were automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such PRSU Award and (ii) the ADS Consideration."}],"balance_after":3285280,"source":{"system":"sec-edgar","filing":"0001104659-25-097966","document":"tm2528014-13_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925097966/tm2528014-13_4seq1.xml","form_type":"4"}},{"id":1021433,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-10-08T20:44:12.000Z","date":"2025-10-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12176144,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents Ordinary Shares of the Issuer acquired from the Reporting Person by means of a scheme of arrangement (the \"Scheme of Arrangement\") under Part 26 of the UK Companies Act 2006, pursuant to a transaction agreement, dated as of July 8, 2025 (the \"Transaction Agreement\"), by and among the Issuer, Merck Sharp & Dohme LLC, a New Jersey limited liability company (\"Parent\") and Vol Holdings LLC, a Delaware limited liability company and wholly owned subsidiary of Parent (\"Bidco\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Scheme of Arrangement (the \"Effective Time\"), each holder of the Scheme Shares (as defined in the Scheme of Arrangement) became entitled to receive $13.375 in cash per Scheme Share, without interest and net of any applicable withholding taxes. Because each ADS represents a beneficial ownership interest in eight (8) Ordinary Shares of the Issuer, holders of ADSs as of the Effective Time became entitled to receive eight (8) times the foregoing cash amount, or $107 in cash, without interest and net of any applicable withholding taxes, per ADS (the \"ADS Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding time-based restricted share unit award (\"RSU Award\"), unless agreed otherwise, became fully vested, and at the Effective Time, was automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such RSU Award and (ii) the ADS Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-25-097966","document":"tm2528014-13_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925097966/tm2528014-13_4seq1.xml","form_type":"4"}},{"id":1049593,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-09-03T20:32:00.000Z","date":"2025-08-29","kind":"gift","planned":false,"acquired":false,"shares":1200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 2,375,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 296,875 ADSs); and (ii) 9,801,144 Ordinary Shares underlying 1,225,143 ADSs."}],"balance_after":12176144,"source":{"system":"sec-edgar","filing":"0001104659-25-087064","document":"tm2525084-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925087064/tm2525084-3_4seq1.xml","form_type":"4"}},{"id":1074501,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2025-08-06T00:22:51.000Z","date":"2025-08-01","kind":"exercise","planned":true,"acquired":false,"shares":55696,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Represents an award of performance-based RSUs covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Represents an award of performance-based RSUs covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs were earned upon the determination by the Board of Directors of the Issuer (the \"Determination Date\") that certain performance metrics related to Q1 2025 had been achieved. The RSUs vested as to 34% of the total shares on the Determination Date, and vest as to the remainder of the shares in equal quarterly installments over a two year period on each of August 1, November 1, February 1 and May 1, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Represents an award of performance-based RSUs covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":389792,"derivative":{"underlying":"Ordinary Shares","underlying_shares":55696},"source":{"system":"sec-edgar","filing":"0001104659-25-074389","document":"tm2522566-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925074389/tm2522566-6_4seq1.xml","form_type":"4"}},{"id":1074500,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2025-08-06T00:22:51.000Z","date":"2025-08-01","kind":"exercise","planned":true,"acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Represents an award of performance-based RSUs covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Represents an award of performance-based RSUs covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs were earned upon the satisfaction of the performance condition in connection with the Issuer's first commercial sale of ensifentrine. Following the satisfaction of the performance condition, the RSUs vest in equal quarterly installments on each of May 1, 2025, August 1, 2025, November 1, 2025, February 1, 2026, May 1, 2026 and August 1, 2026 subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Represents an award of performance-based RSUs covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":800000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-25-074389","document":"tm2522566-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925074389/tm2522566-6_4seq1.xml","form_type":"4"}},{"id":1074499,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-08-06T00:22:51.000Z","date":"2025-08-01","kind":"sale","planned":true,"acquired":false,"shares":208912,"price":13.1437,"value":2745876.6544,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction entered into on May 24, 2022 solely with the intent to cover taxes in connection with the vesting of Restricted Share Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the sale price of the ADSs divided by eight (8)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of (i) 2,375,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 296,875 ADSs); and (ii) 11,001,144 Ordinary Shares underlying 1,375,143 ADSs."}],"balance_after":13376144,"source":{"system":"sec-edgar","filing":"0001104659-25-074389","document":"tm2522566-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925074389/tm2522566-6_4seq1.xml","form_type":"4"}},{"id":1074498,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-08-06T00:22:51.000Z","date":"2025-08-01","kind":"exercise","planned":true,"acquired":true,"shares":255696,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":13585056,"source":{"system":"sec-edgar","filing":"0001104659-25-074389","document":"tm2522566-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925074389/tm2522566-6_4seq1.xml","form_type":"4"}},{"id":1089980,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2025-07-09T22:37:20.000Z","date":"2025-07-07","kind":"exercise","planned":false,"acquired":false,"shares":229512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Represents an award of performance-based Restricted Share Units (\"RSUs\") covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Represents an award of performance-based Restricted Share Units (\"RSUs\") covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents an award of performance-based Restricted Share Units (\"RSUs\") covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs were earned upon the determination by the Board of Directors of the Issuer (the \"Determination Date\") that certain performance metrics related to Q2 2025 had been achieved. The RSUs vested as to 34% of the total shares on the Determination Date, and vest as to the remainder of the shares in equal quarterly installments over a two year period on each of November 1, February 1, May 1 and August 1, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Represents an award of performance-based Restricted Share Units (\"RSUs\") covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":445536,"derivative":{"underlying":"Ordinary Shares","underlying_shares":229512},"source":{"system":"sec-edgar","filing":"0001104659-25-066763","document":"tm2520273-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925066763/tm2520273-1_4seq1.xml","form_type":"4"}},{"id":1089979,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2025-07-09T22:37:20.000Z","date":"2025-07-07","kind":"grant","planned":false,"acquired":true,"shares":675048,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Represents an award of performance-based Restricted Share Units (\"RSUs\") covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Represents an award of performance-based Restricted Share Units (\"RSUs\") covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents an award of performance-based Restricted Share Units (\"RSUs\") covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs were earned upon the determination by the Board of Directors of the Issuer (the \"Determination Date\") that certain performance metrics related to Q2 2025 had been achieved. The RSUs vested as to 34% of the total shares on the Determination Date, and vest as to the remainder of the shares in equal quarterly installments over a two year period on each of November 1, February 1, May 1 and August 1, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Represents an award of performance-based Restricted Share Units (\"RSUs\") covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":675048,"derivative":{"underlying":"Ordinary Shares","underlying_shares":675048},"source":{"system":"sec-edgar","filing":"0001104659-25-066763","document":"tm2520273-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925066763/tm2520273-1_4seq1.xml","form_type":"4"}},{"id":1089978,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-07-09T22:37:20.000Z","date":"2025-07-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":90320,"price":11.4413,"value":1033378.216,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the closing price of the Issuer's ADSs on the Nasdaq Stock Market LLC on July 3, 2025 divided by eight (8)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of (i) 2,450,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 306,250 ADSs); and (ii) 10,879,360 Ordinary Shares underlying 1,359,920 ADSs."}],"balance_after":13329360,"source":{"system":"sec-edgar","filing":"0001104659-25-066763","document":"tm2520273-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925066763/tm2520273-1_4seq1.xml","form_type":"4"}},{"id":1089977,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-07-09T22:37:20.000Z","date":"2025-07-07","kind":"exercise","planned":false,"acquired":true,"shares":229512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":13419680,"source":{"system":"sec-edgar","filing":"0001104659-25-066763","document":"tm2520273-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925066763/tm2520273-1_4seq1.xml","form_type":"4"}},{"id":1111594,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-06-13T20:30:19.000Z","date":"2025-06-11","kind":"sale","planned":true,"acquired":false,"shares":400000,"price":11.4013,"value":4560520.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted on January 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents a weighted average price of the ADSs divided by eight (8). The securities were sold in multiple transactions at prices ranging from $11.375 to $11.46 per Ordinary Share, inclusive (or $91.00 to $91.68 per ADS, inclusive). The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of (i) 2,450,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 306,250 ADSs); and (ii) 10,740,168 Ordinary Shares underlying 1,342,521 ADSs."}],"balance_after":13190168,"source":{"system":"sec-edgar","filing":"0001104659-25-059398","document":"tm2517862-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925059398/tm2517862-1_4seq1.xml","form_type":"4"}},{"id":1130524,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-05-29T20:15:16.000Z","date":"2025-05-29","kind":"sale","planned":true,"acquired":false,"shares":208696,"price":9.3322,"value":1947592.8112,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted on January 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported represents a weighted average price of the ADSs divided by eight (8). The securities were sold in multiple transactions at prices ranging from $9.25 to $9.385 per Ordinary Share, inclusive (or $74.00 to $75.08 per ADS, inclusive). The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Consists of (i) 2,450,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 306,250 ADSs); and (ii) 11,140,168 Ordinary Shares underlying 1,392,521 ADSs."}],"balance_after":13590168,"source":{"system":"sec-edgar","filing":"0001104659-25-054260","document":"tm2516433-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925054260/tm2516433-1_4seq1.xml","form_type":"4"}},{"id":1130523,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-05-29T20:15:16.000Z","date":"2025-05-28","kind":"sale","planned":true,"acquired":false,"shares":157704,"price":9.301,"value":1466804.904,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted on January 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported represents a weighted average price of the ADSs divided by eight (8). The securities were sold in multiple transactions at prices ranging from $9.25 to $9.4513 per Ordinary Share, inclusive (or $74.00 to $75.61 per ADS, inclusive). The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":13798864,"source":{"system":"sec-edgar","filing":"0001104659-25-054260","document":"tm2516433-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925054260/tm2516433-1_4seq1.xml","form_type":"4"}},{"id":1130522,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-05-29T20:15:16.000Z","date":"2025-05-27","kind":"sale","planned":true,"acquired":false,"shares":33600,"price":9.5292,"value":320181.12,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted on January 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents a weighted average price of the ADSs divided by eight (8). The securities were sold in multiple transactions at prices ranging from $9.50 to $9.595 per Ordinary Share, inclusive (or $76.00 to $76.76 per ADS, inclusive). The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":13956568,"source":{"system":"sec-edgar","filing":"0001104659-25-054260","document":"tm2516433-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925054260/tm2516433-1_4seq1.xml","form_type":"4"}},{"id":1159189,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2025-05-05T20:30:15.000Z","date":"2025-05-01","kind":"exercise","planned":true,"acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Represents an award of performance-based Restricted Share Units (\"RSUs\") covering American Depositary Shares (\"ADSs\"), which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Represents an award of performance-based Restricted Share Units (\"RSUs\") covering American Depositary Shares (\"ADSs\"), which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents an award of performance-based Restricted Share Units (\"RSUs\") covering American Depositary Shares (\"ADSs\"), which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The RSUs were earned upon the satisfaction of the performance condition in connection with the Issuer's first commercial sale of ensifentrine. Following the satisfaction of the performance condition, the RSUs vest in equal quarterly installments on each of May 1, 2025, August 1, 2025, November 1, 2025, February 1, 2026, May 1, 2026 and August 1, 2026 subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Represents an award of performance-based Restricted Share Units (\"RSUs\") covering American Depositary Shares (\"ADSs\"), which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":1000000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-25-044530","document":"tm2514016-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925044530/tm2514016-1_4seq1.xml","form_type":"4"}},{"id":1159188,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-05-05T20:30:15.000Z","date":"2025-05-02","kind":"sale","planned":true,"acquired":false,"shares":400000,"price":9.0938,"value":3637520.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted on January 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported represents a weighted average price of the ADSs divided by eight (8). The securities were sold in multiple transactions at prices ranging from $8.91 to $9.2213 per Ordinary Share, inclusive (or $71.28 to $73.77 per ADS, inclusive). The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Consists of (i) 2,450,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 306,250 ADSs); and (ii) 11,540,168 Ordinary Shares underlying 1,442,521 ADSs."}],"balance_after":13990168,"source":{"system":"sec-edgar","filing":"0001104659-25-044530","document":"tm2514016-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925044530/tm2514016-1_4seq1.xml","form_type":"4"}},{"id":1159187,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-05-05T20:30:15.000Z","date":"2025-05-01","kind":"sale","planned":true,"acquired":false,"shares":78736,"price":8.9502,"value":704702.9472,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction entered into on May 24, 2022 solely with the intent to cover taxes in connection with the vesting of Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the sale price of the ADSs divided by eight (8)."}],"balance_after":14390168,"source":{"system":"sec-edgar","filing":"0001104659-25-044530","document":"tm2514016-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925044530/tm2514016-1_4seq1.xml","form_type":"4"}},{"id":1159186,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-05-05T20:30:15.000Z","date":"2025-05-01","kind":"exercise","planned":true,"acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents an award of performance-based Restricted Share Units (\"RSUs\") covering American Depositary Shares (\"ADSs\"), which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."}],"balance_after":14468904,"source":{"system":"sec-edgar","filing":"0001104659-25-044530","document":"tm2514016-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925044530/tm2514016-1_4seq1.xml","form_type":"4"}},{"id":1159185,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-05-05T20:30:15.000Z","date":"2025-05-01","kind":"sale","planned":true,"acquired":false,"shares":108272,"price":8.9502,"value":969056.0544,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction entered into on May 24, 2022 solely with the intent to cover taxes in connection with the vesting of Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the sale price of the ADSs divided by eight (8)."}],"balance_after":14268904,"source":{"system":"sec-edgar","filing":"0001104659-25-044530","document":"tm2514016-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925044530/tm2514016-1_4seq1.xml","form_type":"4"}},{"id":1162425,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2025-05-02T00:58:05.000Z","date":"2025-04-29","kind":"exercise","planned":true,"acquired":false,"shares":229512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Represents an award of performance-based Restricted Share Units (\"RSUs\") covering American Depositary Shares (\"ADSs\"), which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Represents an award of performance-based Restricted Share Units (\"RSUs\") covering American Depositary Shares (\"ADSs\"), which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents an award of performance-based Restricted Share Units (\"RSUs\") covering American Depositary Shares (\"ADSs\"), which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs were earned upon the determination by the Board of Directors of the Issuer (the \"Determination Date\") that certain performance metrics related to Q1 2025 had been achieved. The RSUs vested as to 34% of the total shares on the Determination Date, and vest as to the remainder of the shares in equal quarterly installments over a two year period on each of August 1, November 1, February 1 and May 1, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Represents an award of performance-based Restricted Share Units (\"RSUs\") covering American Depositary Shares (\"ADSs\"), which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":445488,"derivative":{"underlying":"Ordinary Shares","underlying_shares":229512},"source":{"system":"sec-edgar","filing":"0001104659-25-043647","document":"tm2513834-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925043647/tm2513834-4_4seq1.xml","form_type":"4"}},{"id":1162424,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2025-05-02T00:58:05.000Z","date":"2025-04-29","kind":"grant","planned":true,"acquired":true,"shares":675000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Represents an award of performance-based Restricted Share Units (\"RSUs\") covering American Depositary Shares (\"ADSs\"), which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Represents an award of performance-based Restricted Share Units (\"RSUs\") covering American Depositary Shares (\"ADSs\"), which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents an award of performance-based Restricted Share Units (\"RSUs\") covering American Depositary Shares (\"ADSs\"), which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs were earned upon the determination by the Board of Directors of the Issuer (the \"Determination Date\") that certain performance metrics related to Q1 2025 had been achieved. The RSUs vested as to 34% of the total shares on the Determination Date, and vest as to the remainder of the shares in equal quarterly installments over a two year period on each of August 1, November 1, February 1 and May 1, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Represents an award of performance-based Restricted Share Units (\"RSUs\") covering American Depositary Shares (\"ADSs\"), which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":675000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":675000},"source":{"system":"sec-edgar","filing":"0001104659-25-043647","document":"tm2513834-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925043647/tm2513834-4_4seq1.xml","form_type":"4"}},{"id":1162423,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2025-05-02T00:58:05.000Z","date":"2024-08-07","kind":"grant","planned":true,"acquired":true,"shares":1200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Represents an award of performance-based Restricted Share Units (\"RSUs\") covering American Depositary Shares (\"ADSs\"), which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Represents an award of performance-based Restricted Share Units (\"RSUs\") covering American Depositary Shares (\"ADSs\"), which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents an award of performance-based Restricted Share Units (\"RSUs\") covering American Depositary Shares (\"ADSs\"), which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs were earned upon the satisfaction of the performance condition in connection with the Issuer's first commercial sale of ensifentrine. Following the satisfaction of the performance condition, the RSUs vest in equal quarterly installments on each of May 1, 2025, August 1, 2025, November 1, 2025, February 1, 2026, May 1, 2026 and August 1, 2026 subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Represents an award of performance-based Restricted Share Units (\"RSUs\") covering American Depositary Shares (\"ADSs\"), which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":1200000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1200000},"source":{"system":"sec-edgar","filing":"0001104659-25-043647","document":"tm2513834-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925043647/tm2513834-4_4seq1.xml","form_type":"4"}},{"id":1162422,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-05-02T00:58:05.000Z","date":"2025-04-29","kind":"sale","planned":true,"acquired":false,"shares":90360,"price":8.98,"value":811432.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction entered into on May 24, 2022 solely with the intent to cover taxes in connection with the vesting of Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the sale price of the ADSs divided by eight (8)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of (i) 2,725,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 340,625 ADSs); and (ii) 11,652,176 Ordinary Shares underlying 1,456,522 ADSs."}],"balance_after":14377176,"source":{"system":"sec-edgar","filing":"0001104659-25-043647","document":"tm2513834-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925043647/tm2513834-4_4seq1.xml","form_type":"4"}},{"id":1162421,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-05-02T00:58:05.000Z","date":"2025-04-29","kind":"exercise","planned":true,"acquired":true,"shares":229512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":14467536,"source":{"system":"sec-edgar","filing":"0001104659-25-043647","document":"tm2513834-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925043647/tm2513834-4_4seq1.xml","form_type":"4"}},{"id":1284783,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-02-04T21:31:21.000Z","date":"2025-02-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":166728,"price":7.1625,"value":1194189.3,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported represents the closing price of the Issuer's ADSs on the Nasdaq Stock Market LLC on January 31, 2025 divided by eight (8)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Consists of (i) 2,725,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 340,625 ADSs); and (ii) 11,513,024 Ordinary Shares underlying 1,439,128 ADSs."}],"balance_after":14238024,"source":{"system":"sec-edgar","filing":"0001104659-25-009145","document":"tm255463-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925009145/tm255463-3_4seq1.xml","form_type":"4"}},{"id":1284782,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-02-04T21:31:21.000Z","date":"2025-02-01","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an award of Ordinary Shares upon vesting of Performance Restricted Share Units in connection with the Issuer's first commercial sale of ensifentrine."}],"balance_after":14404752,"source":{"system":"sec-edgar","filing":"0001104659-25-009145","document":"tm255463-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465925009145/tm255463-3_4seq1.xml","form_type":"4"}},{"id":1340427,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-12-06T22:51:29.000Z","date":"2024-12-06","kind":"sale","planned":true,"acquired":false,"shares":162800,"price":5.0086,"value":815400.08,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted on March 8, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported represents a weighted average price of the ADSs divided by eight (8). The securities were sold in multiple transactions at prices ranging from $5 to $5.0219 per Ordinary Share, inclusive (or $40.00 to $40.175 per ADS, inclusive). The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Consists of (i) 3,000,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 375,000 ADSs); and (ii) 11,204,752 Ordinary Shares underlying 1,400,594 ADSs."}],"balance_after":14204752,"source":{"system":"sec-edgar","filing":"0001104659-24-126372","document":"tm2430339-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465924126372/tm2430339-2_4seq1.xml","form_type":"4"}},{"id":1340426,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-12-06T22:51:29.000Z","date":"2024-12-05","kind":"sale","planned":true,"acquired":false,"shares":640264,"price":5.0061,"value":3205225.6104,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted on March 8, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported represents a weighted average price of the ADSs divided by eight (8). The securities were sold in multiple transactions at prices ranging from $5 to $5.0313 per Ordinary Share, inclusive (or $40.00 to $40.25 per ADS, inclusive). The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":14367552,"source":{"system":"sec-edgar","filing":"0001104659-24-126372","document":"tm2430339-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465924126372/tm2430339-2_4seq1.xml","form_type":"4"}},{"id":1340425,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-12-06T22:51:29.000Z","date":"2024-12-04","kind":"sale","planned":true,"acquired":false,"shares":67608,"price":5.0018,"value":338161.6944,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted on March 8, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents a weighted average price of the ADSs divided by eight (8). The securities were sold in multiple transactions at prices ranging from $5 to $5.005 per Ordinary Share, inclusive (or $40.00 to $40.04 per ADS, inclusive). The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":15007816,"source":{"system":"sec-edgar","filing":"0001104659-24-126372","document":"tm2430339-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465924126372/tm2430339-2_4seq1.xml","form_type":"4"}},{"id":1347145,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-12-03T00:19:14.000Z","date":"2024-12-02","kind":"sale","planned":true,"acquired":false,"shares":3200,"price":5,"value":16000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted on March 8, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of (i) 3,000,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 375,000 ADSs); and (ii) 12,075,424 Ordinary Shares underlying 1,509,428 ADSs."}],"balance_after":15075424,"source":{"system":"sec-edgar","filing":"0001104659-24-124756","document":"tm2429922-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465924124756/tm2429922-1_4seq1.xml","form_type":"4"}},{"id":1347144,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-12-03T00:19:14.000Z","date":"2024-11-29","kind":"sale","planned":true,"acquired":false,"shares":98888,"price":5.006,"value":495033.328,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted on March 8, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents a weighted average price of the ADSs divided by eight (8). The securities were sold in multiple transactions at prices ranging from $5 to $5.0663 per Ordinary Share, inclusive (or $40.00 to $40.53 per ADS, inclusive). The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":15078624,"source":{"system":"sec-edgar","filing":"0001104659-24-124756","document":"tm2429922-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465924124756/tm2429922-1_4seq1.xml","form_type":"4"}},{"id":1347143,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-12-03T00:19:14.000Z","date":"2024-11-27","kind":"sale","planned":true,"acquired":false,"shares":23240,"price":5,"value":116200.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted on March 8, 2024."}],"balance_after":15177512,"source":{"system":"sec-edgar","filing":"0001104659-24-124756","document":"tm2429922-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465924124756/tm2429922-1_4seq1.xml","form_type":"4"}},{"id":1350903,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-11-26T23:35:54.000Z","date":"2024-11-25","kind":"sale","planned":true,"acquired":false,"shares":1600,"price":5,"value":8000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted on March 8, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Consists of (i) 3,000,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 375,000 ADSs); and (ii) 12,200,752 Ordinary Shares underlying 1,525,094 ADSs."}],"balance_after":15200752,"source":{"system":"sec-edgar","filing":"0001104659-24-123210","document":"tm2429604-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465924123210/tm2429604-2_4seq1.xml","form_type":"4"}},{"id":1366526,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-11-13T21:58:51.000Z","date":"2024-11-11","kind":"sale","planned":true,"acquired":false,"shares":2400,"price":5,"value":12000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted on March 8, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Consists of (i) 3,000,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 375,000 ADSs); and (ii) 12,202,352 Ordinary Shares underlying 1,525,294 ADSs."}],"balance_after":15202352,"source":{"system":"sec-edgar","filing":"0001104659-24-117794","document":"tm2428400-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465924117794/tm2428400-2_4seq1.xml","form_type":"4"}},{"id":1375426,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-11-05T22:41:13.000Z","date":"2024-11-04","kind":"sale","planned":true,"acquired":false,"shares":94144,"price":4.3918,"value":413461.6192,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted on March 8, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported represents a weighted average price of the ADSs divided by eight (8). The securities were sold in multiple transactions at prices ranging from $4.375 to $4.4225 per Ordinary Share, inclusive (or $35.00 to $35.38 per ADS, inclusive). The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Consists of (i) 3,000,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 375,000 ADSs); and (ii) 12,204,752 Ordinary Shares underlying 1,525,594 ADSs."}],"balance_after":15204752,"source":{"system":"sec-edgar","filing":"0001104659-24-114410","document":"tm2427415-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465924114410/tm2427415-2_4seq1.xml","form_type":"4"}},{"id":1375425,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-11-05T22:41:13.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":46888,"price":4.3763,"value":205195.9544,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted on March 8, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents a weighted average price of the ADSs divided by eight (8). The securities were sold in multiple transactions at prices ranging from $4.375 to $4.3825 per Ordinary Share, inclusive (or $35.00 to $35.06 per ADS, inclusive). The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":15298896,"source":{"system":"sec-edgar","filing":"0001104659-24-114410","document":"tm2427415-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465924114410/tm2427415-2_4seq1.xml","form_type":"4"}},{"id":1378184,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-11-01T23:19:41.000Z","date":"2024-11-01","kind":"tax_withholding","planned":true,"acquired":false,"shares":245952,"price":4.2412,"value":1043131.6224,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units and the vesting of the Performance Restricted Share Units described in footnote 3 above."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported represents the closing price of the Issuer's ADSs on the Nasdaq Stock Market LLC on October 31, 2024 divided by eight (8)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Consists of (i) 3,000,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 375000 ADSs); and (ii) 12,345,784 Ordinary Shares underlying 1,543,223 ADSs."}],"balance_after":15345784,"source":{"system":"sec-edgar","filing":"0001104659-24-113579","document":"tm2427350-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465924113579/tm2427350-4_4seq1.xml","form_type":"4"}},{"id":1378183,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-11-01T23:19:41.000Z","date":"2024-11-01","kind":"grant","planned":true,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents an award of Ordinary Shares upon vesting of Performance Restricted Share Units in connection with the Issuer's first commercial sale of ensifentrine."}],"balance_after":15591736,"source":{"system":"sec-edgar","filing":"0001104659-24-113579","document":"tm2427350-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465924113579/tm2427350-4_4seq1.xml","form_type":"4"}},{"id":1378182,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-11-01T23:19:41.000Z","date":"2024-10-30","kind":"grant","planned":true,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents an award of Restricted Share Units (\"RSUs\"), each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer. The RSUs vest over four years, with 1/4th of the RSUs vesting on November 1, 2025 and the balance vesting in 12 equal quarterly installments thereafter."}],"balance_after":15391736,"source":{"system":"sec-edgar","filing":"0001104659-24-113579","document":"tm2427350-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465924113579/tm2427350-4_4seq1.xml","form_type":"4"}},{"id":1381303,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-10-25T23:54:22.000Z","date":"2024-10-25","kind":"sale","planned":true,"acquired":false,"shares":4800,"price":4.3758,"value":21003.84,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted on March 8, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported represents a weighted average price of the ADSs divided by eight (8). The securities were sold in multiple transactions at prices ranging from $4.3750 to $4.3775 per Ordinary Share, inclusive (or $35.00 to $35.02 per ADS, inclusive). The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Consists of (i) 2,825,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 353,125 ADSs); and (ii) 11,766,736 Ordinary Shares underlying 1,470,842 ADSs."}],"balance_after":14591736,"source":{"system":"sec-edgar","filing":"0001104659-24-111566","document":"tm2426806-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465924111566/tm2426806-1_4seq1.xml","form_type":"4"}},{"id":1381302,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-10-25T23:54:22.000Z","date":"2024-10-24","kind":"sale","planned":true,"acquired":false,"shares":140000,"price":4.3773,"value":612822.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted on March 8, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents a weighted average price of the ADSs divided by eight (8). The securities were sold in multiple transactions at prices ranging from $4.3750 to $4.3963 per Ordinary Share, inclusive (or $35.00 to $35.17 per ADS, inclusive). The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":14596536,"source":{"system":"sec-edgar","filing":"0001104659-24-111566","document":"tm2426806-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465924111566/tm2426806-1_4seq1.xml","form_type":"4"}},{"id":1381301,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-10-25T23:54:22.000Z","date":"2024-10-23","kind":"sale","planned":true,"acquired":false,"shares":16,"price":4.375,"value":70.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted on March 8, 2024."}],"balance_after":14736536,"source":{"system":"sec-edgar","filing":"0001104659-24-111566","document":"tm2426806-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465924111566/tm2426806-1_4seq1.xml","form_type":"4"}},{"id":1382908,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-10-23T00:46:22.000Z","date":"2024-10-22","kind":"sale","planned":true,"acquired":false,"shares":157912,"price":4.3868,"value":692728.3616,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted on March 8, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported represents a weighted average price of the ADSs divided by eight (8). The securities were sold in multiple transactions at prices ranging from $4.375 to $4.4438 per Ordinary Share, inclusive (or $35.00 to $35.55 per ADS, inclusive). The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Consists of (i) 2,825,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 353,125 ADSs); and (ii) 11,911,552 Ordinary Shares underlying 1,488,944 ADSs."}],"balance_after":14736552,"source":{"system":"sec-edgar","filing":"0001104659-24-110659","document":"tm2426639-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465924110659/tm2426639-2_4seq1.xml","form_type":"4"}},{"id":1382907,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-10-23T00:46:22.000Z","date":"2024-10-21","kind":"sale","planned":true,"acquired":false,"shares":110456,"price":4.3796,"value":483753.0976,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted on March 8, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported represents a weighted average price of the ADSs divided by eight (8). The securities were sold in multiple transactions at prices ranging from $4.3750 to $4.3913 per Ordinary Share, inclusive (or $35.00 to $35.13 per ADS, inclusive). The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":14894464,"source":{"system":"sec-edgar","filing":"0001104659-24-110659","document":"tm2426639-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465924110659/tm2426639-2_4seq1.xml","form_type":"4"}},{"id":1382906,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-10-23T00:46:22.000Z","date":"2024-10-18","kind":"sale","planned":true,"acquired":false,"shares":245784,"price":4.3809,"value":1076755.1256,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted on March 8, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents a weighted average price of the ADSs divided by eight (8). The securities were sold in multiple transactions at prices ranging from $4.3750 to $4.4063 per Ordinary Share, inclusive (or $35.00 to $35.25 per ADS, inclusive). The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":15004920,"source":{"system":"sec-edgar","filing":"0001104659-24-110659","document":"tm2426639-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465924110659/tm2426639-2_4seq1.xml","form_type":"4"}},{"id":1407646,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-09-13T20:15:50.000Z","date":"2024-09-11","kind":"sale","planned":true,"acquired":false,"shares":600000,"price":3.7572,"value":2254320.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted on March 8, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents a weighted average price of the ADSs divided by eight (8). The securities were sold in multiple transactions at prices ranging from $3.75 to $3.7888 per Ordinary Share, inclusive (or $30.00 to $30.31 per ADS, inclusive). The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of (i) 2,825,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 353,125 ADSs); and (ii) 12,425,704 Ordinary Shares underlying 1,553,213 ADSs."}],"balance_after":15250704,"source":{"system":"sec-edgar","filing":"0001104659-24-099794","document":"tm2423975-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465924099794/tm2423975-2_4seq1.xml","form_type":"4"}},{"id":1433606,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-08-14T20:16:10.000Z","date":"2024-08-13","kind":"sale","planned":true,"acquired":false,"shares":8216,"price":3.25,"value":26702.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted on March 8, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the ADS sale price on the Nasdaq Stock Market LLC divided by eight (8)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Consists of (i) 2,825,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 353,125 ADSs); and (ii) 13,025,704 Ordinary Shares underlying 1,628,213 ADSs."}],"balance_after":15850704,"source":{"system":"sec-edgar","filing":"0001104659-24-089644","document":"tm2421466d3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465924089644/tm2421466d3_4seq1.xml","form_type":"4"}},{"id":1433605,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-08-14T20:16:10.000Z","date":"2024-08-13","kind":"sale","planned":true,"acquired":false,"shares":390184,"price":3.201,"value":1248978.984,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted on March 8, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported represents a weighted average price of the ADSs divided by eight (8). The securities were sold in multiple transactions at prices ranging from $3.125 to $3.246875 per Ordinary Share, inclusive (or $25.00 to $25.99 per ADS, inclusive). The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":15858920,"source":{"system":"sec-edgar","filing":"0001104659-24-089644","document":"tm2421466d3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465924089644/tm2421466d3_4seq1.xml","form_type":"4"}},{"id":1433604,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-08-14T20:16:10.000Z","date":"2024-08-12","kind":"sale","planned":true,"acquired":false,"shares":1600,"price":3.13,"value":5008.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted on March 8, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the ADS sale price on the Nasdaq Stock Market LLC divided by eight (8)."}],"balance_after":16249104,"source":{"system":"sec-edgar","filing":"0001104659-24-089644","document":"tm2421466d3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465924089644/tm2421466d3_4seq1.xml","form_type":"4"}},{"id":1436910,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-08-09T23:13:47.000Z","date":"2024-08-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":314800,"price":2.62,"value":824776.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of the Performance Restricted Share Units described in footnote 2 above."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported represents the closing price of the Issuer's ADSs on the Nasdaq Stock Market LLC on August 6, 2024 divided by eight (8)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Consists of (i) 2,825,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 353,125 ADSs); and (ii) 13,425,704 Ordinary Shares underlying 1,678,213 ADSs."}],"balance_after":16250704,"source":{"system":"sec-edgar","filing":"0001104659-24-087930","document":"tm2421367-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465924087930/tm2421367-3_4seq1.xml","form_type":"4"}},{"id":1436909,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-08-09T23:13:47.000Z","date":"2024-08-07","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents an award of Ordinary Shares upon vesting of Performance Restricted Share Units in connection with the Issuer's first commercial sale of ensifentrine."}],"balance_after":16565504,"source":{"system":"sec-edgar","filing":"0001104659-24-087930","document":"tm2421367-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465924087930/tm2421367-3_4seq1.xml","form_type":"4"}},{"id":1440724,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-08-06T01:29:47.000Z","date":"2024-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":88544,"price":2.8325,"value":250800.88,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the closing price of the Issuer's ADSs on the Nasdaq Stock Market LLC on July 31, 2024 divided by eight (8)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of (i) 2,825,000  Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by  353,125 ADSs); and (ii) 12,940,504  Ordinary Shares underlying 1,617,563 ADSs."}],"balance_after":15765504,"source":{"system":"sec-edgar","filing":"0001104659-24-086002","document":"tm2420861-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465924086002/tm2420861-2_4seq1.xml","form_type":"4"}},{"id":1528160,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-05-03T23:19:51.000Z","date":"2024-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":88544,"price":1.9313,"value":171005.0272,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the closing price of the Issuer's ADSs on the Nasdaq Stock Market LLC on April 30, 2024 divided by eight (8)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of (i) 3,050,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 381,250 ADSs); and (ii) 12,804,048 Ordinary Shares underlying 1,600,506 ADSs."}],"balance_after":15854048,"source":{"system":"sec-edgar","filing":"0001104659-24-057113","document":"tm2413470-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465924057113/tm2413470-1_4seq1.xml","form_type":"4"}},{"id":1658850,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-02-05T23:11:23.000Z","date":"2024-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":480200,"price":2.2938,"value":1101482.76,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the closing price of the Issuer's ADSs on the Nasdaq Stock Market LLC on January 31, 2024 divided by eight (8)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of (i) 3,275,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 409,375 ADSs); and (ii) 12,667,592 Ordinary Shares underlying 1,583,449 ADSs."}],"balance_after":15942592,"source":{"system":"sec-edgar","filing":"0001104659-24-010788","document":"tm245245-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465924010788/tm245245-4_4seq1.xml","form_type":"4"}},{"id":1749789,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2023-11-04T00:09:14.000Z","date":"2023-11-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":809008,"price":1.7438,"value":1410748.1504,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the closing price of the Issuer's ADSs on the Nasdaq Stock Market LLC on October 31, 2023 divided by eight (8)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of (i) 4,655,928 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 581,991 ADSs); and (ii) 11,766,864 Ordinary Shares underlying 1,470,858 ADSs."}],"balance_after":16422792,"source":{"system":"sec-edgar","filing":"0001104659-23-114405","document":"tm2329834-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465923114405/tm2329834-2_4seq1.xml","form_type":"4"}},{"id":1755666,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2023-10-24T20:06:57.000Z","date":"2023-10-20","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an award of Restricted Share Units (\"RSUs\"), each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer. The RSUs vest over four years, with 200,000 RSUs vesting on November 1, 2024 and the balance vesting in 12 equal quarterly installments thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Consists of (i) 6,711,840 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 838,980 ADSs); and (ii) 10,519,960 Ordinary Shares underlying 1,314,995 ADSs."}],"balance_after":17231800,"source":{"system":"sec-edgar","filing":"0001104659-23-111094","document":"tm2329036-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465923111094/tm2329036-4_4seq1.xml","form_type":"4"}},{"id":1813815,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2023-08-08T01:17:42.000Z","date":"2023-08-07","kind":"sale","planned":true,"acquired":false,"shares":8616,"price":2.4679,"value":21263.4264,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on March 24, 2022 solely with the intent to cover taxes in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the sale price of the ADSs divided by eight (8)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of (i) 5,911,840 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 738,980 ADSs); and (ii) 10,519,960 Ordinary Shares underlying 1,314,995 ADSs."}],"balance_after":16431800,"source":{"system":"sec-edgar","filing":"0001104659-23-088492","document":"tm2323103-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465923088492/tm2323103-3_4seq1.xml","form_type":"4"}},{"id":1813814,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2023-08-08T01:17:42.000Z","date":"2023-08-04","kind":"sale","planned":true,"acquired":false,"shares":150000,"price":2.4992,"value":374880.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on March 24, 2022 solely with the intent to cover taxes in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the sale price of the ADSs divided by eight (8)."}],"balance_after":16440416,"source":{"system":"sec-edgar","filing":"0001104659-23-088492","document":"tm2323103-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465923088492/tm2323103-3_4seq1.xml","form_type":"4"}},{"id":1813813,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2023-08-08T01:17:42.000Z","date":"2023-08-03","kind":"sale","planned":true,"acquired":false,"shares":117272,"price":2.539,"value":297753.608,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on March 24, 2022 solely with the intent to cover taxes in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the sale price of the ADSs divided by eight (8)."}],"balance_after":16590416,"source":{"system":"sec-edgar","filing":"0001104659-23-088492","document":"tm2323103-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465923088492/tm2323103-3_4seq1.xml","form_type":"4"}},{"id":1816346,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2023-08-04T00:29:02.000Z","date":"2023-08-02","kind":"sale","planned":true,"acquired":false,"shares":73704,"price":2.593,"value":191114.472,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on March 24, 2022 solely with the intent to cover taxes in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the sale price of the ADSs divided by eight (8)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of (i) 5,911,840 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 738,980 ADSs); and (ii) 10,795,848 Ordinary Shares underlying 1,349,481 ADSs."}],"balance_after":16707688,"source":{"system":"sec-edgar","filing":"0001104659-23-087441","document":"tm2322845-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465923087441/tm2322845-2_4seq1.xml","form_type":"4"}},{"id":1816345,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2023-08-04T00:29:02.000Z","date":"2023-08-01","kind":"sale","planned":true,"acquired":false,"shares":105944,"price":2.679,"value":283823.976,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on March 24, 2022 solely with the intent to cover taxes in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the sale price of the ADSs divided by eight (8)."}],"balance_after":16781392,"source":{"system":"sec-edgar","filing":"0001104659-23-087441","document":"tm2322845-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465923087441/tm2322845-2_4seq1.xml","form_type":"4"}},{"id":1906095,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2023-05-03T23:46:45.000Z","date":"2023-05-01","kind":"sale","planned":true,"acquired":false,"shares":455536,"price":2.5759,"value":1173415.1824,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on May 24, 2022 solely with the intent to cover taxes in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the sale price of the ADSs divided by eight (8)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of (i) 7,067,760 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 883,470 ADSs); and (ii) 9,819,576 Ordinary Shares underlying 1,227,447 ADSs."}],"balance_after":16887336,"source":{"system":"sec-edgar","filing":"0001104659-23-055646","document":"tm2314588-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465923055646/tm2314588-1_4seq1.xml","form_type":"4"}},{"id":2032942,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2023-02-03T23:18:16.000Z","date":"2023-02-01","kind":"sale","acquired":false,"shares":432928,"price":2.5572,"value":1107083.4816,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover taxes in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the sale price of the ADSs divided by eight (8)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of (i) 8,223,680 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 1,027,960 ADSs); and (ii) 9,119,192 Ordinary Shares underlying 1,139,899 ADSs."}],"balance_after":17342872,"source":{"system":"sec-edgar","filing":"0001104659-23-010734","document":"tm235387-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465923010734/tm235387-3_4seq1.xml","form_type":"4"}},{"id":2078797,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-12-21T21:06:20.000Z","date":"2022-12-20","kind":"sale","acquired":false,"shares":600000,"price":2.116,"value":1269600.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 25, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the weighted average sale price of the ADSs divided by eight (8). These shares were sold in multiple transactions at prices ranging from $2.065 to $2.1688, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of (i) 9,463,200 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 1,182,900 ADSs); and (ii) 8,312,600 Ordinary Shares underlying 1,039,075 ADSs."}],"balance_after":17775800,"source":{"system":"sec-edgar","filing":"0001104659-22-129085","document":"tm2233201-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465922129085/tm2233201-2_4seq1.xml","form_type":"4"}},{"id":2125603,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-11-03T20:06:09.000Z","date":"2022-11-01","kind":"sale","acquired":false,"shares":32904,"price":1.6726,"value":55035.2304,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover taxes in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported represents the sale price of the ADSs divided by eight (8)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Consists of (i) 9,463,200 Ordinary Shares underlying RSUs (which are represented by 1,182,900 ADSs); and (ii) 8,912,600 Ordinary Shares underlying 1,114,075 ADSs."}],"balance_after":18375800,"source":{"system":"sec-edgar","filing":"0001104659-22-114416","document":"tm2229640-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465922114416/tm2229640-3_4seq1.xml","form_type":"4"}},{"id":2125602,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-11-03T20:06:09.000Z","date":"2022-11-01","kind":"tax_withholding","acquired":false,"shares":454856,"price":1.6,"value":727769.6,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the closing price of the Issuer's ADSs on the Nasdaq Stock Market LLC on October 31, 2022 divided by eight (8)."}],"balance_after":18408704,"source":{"system":"sec-edgar","filing":"0001104659-22-114416","document":"tm2229640-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465922114416/tm2229640-3_4seq1.xml","form_type":"4"}},{"id":2149931,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-09-28T20:05:57.000Z","date":"2022-09-26","kind":"grant","acquired":true,"shares":3600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an award of Restricted Share Units (\"RSUs\"), each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer. The RSUs vest over four years, with 900,000 RSUs vesting on November 1, 2023 and the balance vesting in 12 equal quarterly installments thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Consists of (i) 10,702,720 Ordinary Shares underlying RSUs (which are represented by 1,337,840 ADSs); and (ii) 8,160,840 Ordinary Shares underlying 1,020,105 ADSs."}],"balance_after":18863560,"source":{"system":"sec-edgar","filing":"0001104659-22-103709","document":"tm2226815-1_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465922103709/tm2226815-1_4seq.xml","form_type":"4"}},{"id":2188112,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-08-12T01:46:45.000Z","date":"2022-08-09","kind":"sale","acquired":false,"shares":600000,"price":1.75,"value":1050000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 25, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the sale price of the ADSs divided by eight (8)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of (i) 7,102,720 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of\nthe Issuer (which are represented by 887,840 ADSs); and (ii) 8,160,840 Ordinary Shares underlying 1,020,105 ADSs."}],"balance_after":15263560,"source":{"system":"sec-edgar","filing":"0001104659-22-089568","document":"tm2223116-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465922089568/tm2223116-2_4seq1.xml","form_type":"4"}},{"id":2195781,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-08-03T20:12:15.000Z","date":"2022-08-01","kind":"sale","acquired":false,"shares":32904,"price":0.6998,"value":23026.2192,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover taxes in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported represents the sale price of the ADSs divided by eight (8)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Consists of (i) 7,102,720 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 887,840 ADSs); and (ii) 8,760,840 Ordinary Shares underlying 1,095,105 ADSs."}],"balance_after":15863560,"source":{"system":"sec-edgar","filing":"0001104659-22-085630","document":"tm2222419-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465922085630/tm2222419-4_4seq1.xml","form_type":"4"}},{"id":2195780,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-08-03T20:12:15.000Z","date":"2022-08-01","kind":"tax_withholding","acquired":false,"shares":454864,"price":0.6725,"value":305896.04,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the closing price of the Issuer's ADSs on the Nasdaq Stock Market LLC on July 29, 2022 divided by eight (8)."}],"balance_after":15896464,"source":{"system":"sec-edgar","filing":"0001104659-22-085630","document":"tm2222419-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465922085630/tm2222419-4_4seq1.xml","form_type":"4"}},{"id":2280855,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-05-05T23:20:22.000Z","date":"2022-05-03","kind":"sale","acquired":false,"shares":32904,"price":0.4956,"value":16307.2224,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover taxes in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the sale price of the ADSs divided by eight (8)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of (i) 8,342,256 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 1,042,782 ADSs); and (ii) 8,009,072 Ordinary Shares underlying 1,001,134 ADSs."}],"balance_after":16351328,"source":{"system":"sec-edgar","filing":"0001104659-22-056608","document":"tm2214628-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465922056608/tm2214628-3_4seq1.xml","form_type":"4"}},{"id":2284275,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-05-04T00:17:15.000Z","date":"2022-05-01","kind":"tax_withholding","acquired":false,"shares":454864,"price":0.5225,"value":237666.44,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the closing price of the Issuer's ADSs on the Nasdaq Stock Market LLC on April 29, 2022 divided by eight (8)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of (i) 8,342,256 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 1,042,782 ADSs); and (ii) 8,041,976 Ordinary Shares underlying 1,005,247 ADSs."}],"balance_after":16384232,"source":{"system":"sec-edgar","filing":"0001104659-22-055447","document":"tm2214387-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465922055447/tm2214387-1_4seq1.xml","form_type":"4"}},{"id":2413968,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-02-03T22:56:50.000Z","date":"2022-02-03","kind":"sale","acquired":false,"shares":52056,"price":0.7256,"value":37771.8336,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price, and is based on the sale price of the ADSs divided by eight (8). The securities were sold in multiple transactions at per share prices ranging from $0.7150 to $0.7413. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 5."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Consists of (i) 9,581,792 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 1,197,724 ADSs); and (ii) 7,257,304 Ordinary Shares underlying 907,163 ADSs."}],"balance_after":16839096,"source":{"system":"sec-edgar","filing":"0001104659-22-011440","document":"tm225347-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465922011440/tm225347-3_4seq1.xml","form_type":"4"}},{"id":2413967,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-02-03T22:56:50.000Z","date":"2022-02-01","kind":"tax_withholding","acquired":false,"shares":288648,"price":0.7763,"value":224077.4424,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported represents the closing price of the Issuer's ADSs on the Nasdaq Stock Market LLC on January 31, 2022 divided by eight (8)."}],"balance_after":16891152,"source":{"system":"sec-edgar","filing":"0001104659-22-011440","document":"tm225347-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465922011440/tm225347-3_4seq1.xml","form_type":"4"}},{"id":2413966,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-02-03T22:56:50.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":334448,"price":0.7475,"value":249999.88,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the closing price of the Issuer's ADSs on the Nasdaq Stock Market LLC on January 28, 2022 divided by eight (8)."}],"balance_after":17179800,"source":{"system":"sec-edgar","filing":"0001104659-22-011440","document":"tm225347-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465922011440/tm225347-3_4seq1.xml","form_type":"4"}},{"id":2526309,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2021-11-03T23:52:32.000Z","date":"2021-11-02","kind":"sale","acquired":false,"shares":52056,"price":0.6411,"value":33373.1016,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price, and is based on the sale price of the ADSs divided by eight (8). The securities were sold in multiple transactions at per share prices ranging from $0.6525 to $0.6313. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 5."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Consists of (i) 10,535,528 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 1,316,941 ADSs); and (ii) 6,309,824 Ordinary Shares underlying 788,728 ADSs."}],"balance_after":16845352,"source":{"system":"sec-edgar","filing":"0001104659-21-133857","document":"tm2131837-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465921133857/tm2131837-3_4seq1.xml","form_type":"4"}},{"id":2526308,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2021-11-03T23:52:32.000Z","date":"2021-11-01","kind":"tax_withholding","acquired":false,"shares":454848,"price":0.64,"value":291102.72,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the closing price of the Issuer's ADSs on the Nasdaq Stock Market LLC on October 29, 2021 divided by eight (8)."}],"balance_after":16897408,"source":{"system":"sec-edgar","filing":"0001104659-21-133857","document":"tm2131837-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465921133857/tm2131837-3_4seq1.xml","form_type":"4"}},{"id":2610067,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2021-08-10T00:58:33.000Z","date":"2021-08-03","kind":"sale","acquired":false,"shares":17656,"price":0.7524,"value":13284.3744,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price, and is based on the sale price of the ADSs divided by eight (8). The securities were sold in multiple transactions at per share prices ranging from $0.7338 to $0.7813. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of (i) 11,823,712 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 1,477,964 ADSs); and (ii) 5,528,544 Ordinary Shares underlying 691,068 ADSs."}],"balance_after":17352256,"source":{"system":"sec-edgar","filing":"0001104659-21-102403","document":"tm2124631-10_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465921102403/tm2124631-10_4seq1.xml","form_type":"4"}},{"id":2614843,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2021-08-05T00:12:28.000Z","date":"2021-08-04","kind":"sale","acquired":false,"shares":18400,"price":0.7432,"value":13674.88,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price, and is based on the sale price of the ADSs divided by eight (8). The securities were sold in multiple transactions at per share prices ranging from $0.7288 to $0.7538. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 6."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Consists of (i) 11,823,712 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 1,477,964 ADSs); and (ii) 5,546,200 Ordinary Shares underlying 693,275  ADSs."}],"balance_after":17369912,"source":{"system":"sec-edgar","filing":"0001104659-21-100281","document":"tm2124077-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465921100281/tm2124077-4_4seq1.xml","form_type":"4"}},{"id":2614842,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2021-08-05T00:12:28.000Z","date":"2021-08-03","kind":"sale","acquired":false,"shares":16000,"price":0.7631,"value":12209.6,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price, and is based on the sale price of the ADSs divided by eight (8). The securities were sold in multiple transactions at per share prices ranging from $0.75 to $0.79. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 5."}],"balance_after":17388312,"source":{"system":"sec-edgar","filing":"0001104659-21-100281","document":"tm2124077-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465921100281/tm2124077-4_4seq1.xml","form_type":"4"}},{"id":2614841,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2021-08-05T00:12:28.000Z","date":"2021-08-01","kind":"tax_withholding","acquired":false,"shares":454848,"price":0.785,"value":357055.68,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the closing price of the Issuer's ADSs on the Nasdaq Stock Market LLC on July 30, 2021 divided by eight (8)."}],"balance_after":17404312,"source":{"system":"sec-edgar","filing":"0001104659-21-100281","document":"tm2124077-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465921100281/tm2124077-4_4seq1.xml","form_type":"4"}},{"id":2727248,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2021-05-05T20:06:45.000Z","date":"2021-05-04","kind":"sale","acquired":false,"shares":52056,"price":0.8054,"value":41925.9024,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price, and is based on the sale price of the ADSs divided by eight (8). The securities were sold in multiple transactions at per share prices ranging from $0.7813 to $0.8688. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Consists of (i) 13,111,912 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 1,638,989 ADSs); and (ii) 4,747,248 Ordinary Shares underlying 593,406 ADSs."}],"balance_after":17859160,"source":{"system":"sec-edgar","filing":"0001104659-21-061710","document":"tm2115267-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465921061710/tm2115267-2_4seq1.xml","form_type":"4"}},{"id":2727247,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2021-05-05T20:06:45.000Z","date":"2021-05-03","kind":"tax_withholding","acquired":false,"shares":2139632,"price":0.8875,"value":1898923.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the closing price of the Issuer's ADSs on the Nasdaq Stock Market LLC on May 3, 2021 divided by eight (8)."}],"balance_after":17911216,"source":{"system":"sec-edgar","filing":"0001104659-21-061710","document":"tm2115267-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465921061710/tm2115267-2_4seq1.xml","form_type":"4"}},{"id":2813417,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2021-03-04T01:03:51.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":43392,"price":1.1437,"value":49627.4304,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of Restricted Share Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price, and is based on the sale price of the ADSs divided by eight (8). The securities were sold in multiple transactions at per share prices ranging from $1.1188 to $1.1575. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of (i) 19,023,792 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 2,377,974 ADSs); and (ii) 1,027,056 Ordinary Shares underlying 128,382 ADSs."}],"balance_after":20050848,"source":{"system":"sec-edgar","filing":"0001104659-21-031699","document":"tm218588-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465921031699/tm218588-3_4seq1.xml","form_type":"4"}},{"id":2888626,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2021-02-02T01:54:16.000Z","date":"2021-01-28","kind":"grant","acquired":true,"shares":529104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 19,201,992 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 2,400,249 ADSs); and (ii) 892,248 Ordinary Shares represented by 111,531 ADSs."}],"balance_after":20094240,"source":{"system":"sec-edgar","filing":"0001104659-21-010411","document":"tm214905-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000110465921010411/tm214905-2_4seq1.xml","form_type":"4"}},{"id":3374618,"issuer":{"id":153784,"kind":"organization","name":"Dova Pharmaceuticals Inc.","symbol":"DOVA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-11-12T16:42:57.000Z","date":"2019-11-12","kind":"disposition_to_issuer","acquired":false,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option, which provided for vesting over a period of four years as follows: 25% of the total shares subject to the option shall vest on December 17, 2019, and 1/48th of total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, was accelerated and canceled in the Merger in exchange for a cash payment of $21,430,000.00, representing the difference between the exercise price of outstanding shares subject to the option and the market value of the underlying common stock on the effective date of the Merger ($27.50 per share). In addition, one non-transferable contingent value right per share, which represents the right to receive $1.50, without interest and subject to any withholding taxes, upon the achievement of a specified milestone was awarded to the Reporting Person for each outstanding share subject to the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, which provided for vesting over a period of four years as follows: 25% of the total shares subject to the option shall vest on December 17, 2019, and 1/48th of total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, was accelerated and canceled in the Merger in exchange for a cash payment of $21,430,000.00, representing the difference between the exercise price of outstanding shares subject to the option and the market value of the underlying common stock on the effective date of the Merger ($27.50 per share). In addition, one non-transferable contingent value right per share, which represents the right to receive $1.50, without interest and subject to any withholding taxes, upon the achievement of a specified milestone was awarded to the Reporting Person for each outstanding share subject to the option."}],"balance_after":0,"derivative":{"exercise_price":6.07,"expiration_date":"2018-12-18","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001209191-19-056047","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1685071/000120919119056047/doc4.xml","form_type":"4"}},{"id":3374617,"issuer":{"id":153784,"kind":"organization","name":"Dova Pharmaceuticals Inc.","symbol":"DOVA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-11-12T16:42:57.000Z","date":"2019-11-12","kind":"disposition_to_issuer","acquired":false,"shares":76647,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed pursuant to an agreement and plan of merger by and between the Issuer, Swedish Orphan Biovitrum AB and Dragonfly Acquisition Corp. (the \"Merger\") in exchange for $27.50 per share of Issuer's common stock including any shares subject to each restricted stock unit on the effective date of the Merger, plus (ii) one non-transferable contingent value right per share, which  represents the right to receive $1.50, without interest and subject to any withholding taxes, upon the achievement of a specified milestone."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed pursuant to an agreement and plan of merger by and between the Issuer, Swedish Orphan Biovitrum AB and Dragonfly Acquisition Corp. (the \"Merger\") in exchange for $27.50 per share of Issuer's common stock including any shares subject to each restricted stock unit on the effective date of the Merger, plus (ii) one non-transferable contingent value right per share, which  represents the right to receive $1.50, without interest and subject to any withholding taxes, upon the achievement of a specified milestone."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-056047","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685071/000120919119056047/doc4.xml","form_type":"4"}},{"id":3401162,"issuer":{"id":153784,"kind":"organization","name":"Dova Pharmaceuticals Inc.","symbol":"DOVA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-10-02T16:21:19.000Z","date":"2019-10-01","kind":"sale","acquired":false,"shares":5275,"price":27.9,"value":147172.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person with the intent to cover withholding taxes in connection with the settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.84 to $28.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":76647,"source":{"system":"sec-edgar","filing":"0001562180-19-005059","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685071/000156218019005059/primarydocument.xml","form_type":"4"}},{"id":3468133,"issuer":{"id":153784,"kind":"organization","name":"Dova Pharmaceuticals Inc.","symbol":"DOVA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-07-03T16:24:27.000Z","date":"2019-07-02","kind":"sale","acquired":false,"shares":4551,"price":16.22,"value":73817.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person with the intent to cover withholding taxes in connection with the settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.09 to $16.50 inclusive."}],"balance_after":81922,"source":{"system":"sec-edgar","filing":"0001209191-19-041095","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1685071/000120919119041095/doc4.xml","form_type":"4"}},{"id":3468132,"issuer":{"id":153784,"kind":"organization","name":"Dova Pharmaceuticals Inc.","symbol":"DOVA"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-07-03T16:24:27.000Z","date":"2019-07-02","kind":"sale","acquired":false,"shares":5899,"price":15.73,"value":92791.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person with the intent to cover withholding taxes in connection with the settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.09 to $16.08 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) and (3) to this Form 4."}],"balance_after":86473,"source":{"system":"sec-edgar","filing":"0001209191-19-041095","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685071/000120919119041095/doc4.xml","form_type":"4"}},{"id":3492752,"issuer":{"id":154249,"kind":"organization","name":"MELINTA THERAPEUTICS, INC. /NEW/","symbol":"MLNT"},"owners":[{"id":31235,"kind":"person","name":"ZACCARDELLI DAVID","position":1,"cik":"0001627642","reported_name":"ZACCARDELLI DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Melinta Restricted Stock Units","published_at":"2019-06-12T17:36:48.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units will vest on the day before the 2020 Annual Meeting of Shareholders, or approximately June 7, 2020, subject to continued service with the Issuer through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units will vest on the day before the 2020 Annual Meeting of Shareholders, or approximately June 7, 2020, subject to continued service with the Issuer through the applicable vesting date."}],"balance_after":30000,"derivative":{"exercise_price":0,"underlying":"Melinta Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001461993-19-000030","document":"wf-form4_156036099405068.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627642/000146199319000030/wf-form4_156036099405068.xml","form_type":"4"}}],"next_cursor":"2019-06-12T17:36:48.000000Z,3492752"}